Harmony Biosciences (NASDAQ:HRMY) Trading Down 5.8% After Earnings Miss

Shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY – Get Free Report) fell 5.8% during mid-day trading on Thursday following a weaker than expected earnings announcement. The company traded as low as $29.51 and last traded at $31.08. 327,111 shares were traded during mid-day trading, an increase of 1% from the average session volume of 324,257 […]

Related Keywords

United States ,China ,America ,Raymond James ,Harmony Biosciences Holdings Inc ,China Universal Asset Management Co ,Nasdaq ,Harmony Biosciences Company Profile ,Lazard Asset Management ,Wealth Partners ,Quadrant Capital Group ,Cantor Fitzgerald ,Goldman Sachs Group ,Harmony Biosciences Holdings ,Get Free Report ,Harmony Biosciences ,Capital Group ,Universal Asset Management ,Biosciences Holdings ,Harmony Biosciences Daily ,Nasdaq Hrmy ,Thrmy ,Medical ,Stocks ,Technicals ,